Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non–Small-Cell Lung Cancer in the Netherlands

PURPOSE: A large number of targeted treatment options for stage IV nonsquamous non–small-cell lung cancer with specific genetic aberrations in tumor DNA is available. It is therefore important to optimize diagnostic testing strategies, such that patients receive adequate personalized treatment that...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolff, Henri B., Steeghs, Elisabeth M.P., Mfumbilwa, Zakile A., Groen, Harry J.M., Adang, Eddy M., Willems, Stefan M., Grünberg, Katrien, Schuuring, Ed, Ligtenberg, Marjolijn J.L., Tops, Bastiaan B.J., Coupé, Veerle M.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307305/
https://www.ncbi.nlm.nih.gov/pubmed/35834758
http://dx.doi.org/10.1200/PO.22.00201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307305/
https://www.ncbi.nlm.nih.gov/pubmed/35834758
http://dx.doi.org/10.1200/PO.22.00201

Ejemplares similares